JAMA CATCH Trial: Single-Pill Combination Controlled Blood Pressure in 69.5% vs 29.2% of 1,706 Patients

Results of the CATCH randomized clinical trial, published in JAMA on November 8, 2026, and presented in the Late-Breaking Science sessions of the American Heart Association Scientific Sessions, show that combining antihypertensive medicines into a single pill, delivered with team-based care, lowered blood pressure more effectively than usual multi-pill treatment. The trial enrolled 1,706 patients with uncontrolled hypertension at 40 primary care clinics in Colombia and Jamaica and was co-led by UT Southwestern Medical Center researchers with colleagues in Colombia, Jamaica, and the United States over four years.
After 18 months, systolic blood pressure fell by 19.1 mm Hg in the single-pill group versus 9.0 mm Hg with usual care. The share reaching the trial goal — systolic below 130 mm Hg and diastolic below 80 mm Hg — was 69.5% with the single-pill combination versus 29.2% with standard care. Serious adverse events occurred in 7.9% versus 9.9% of patients, respectively. The single pill combined two or three agents: valsartan, amlodipine, and, if needed, hydrochlorothiazide.
Six months after the trial ended, 75% of patients in the intervention group were still receiving single-pill combination treatment covered by health insurance or government programs and maintained better blood pressure control, which the researchers describe as evidence the strategy is sustainable. The study was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health (UG3/UH3 HL152373).
Reported limitations include the open-label design, in which patients and clinicians knew the treatment assignment, and conduct in only two countries, so confirmation elsewhere is still needed; the intervention also combined the pill with team support, training, coaching, home monitoring, and audit, so the trial cannot separate the pill's effect from the support around it. This report presents trial facts only and makes no individual medication recommendation.
Source: JAMA
Published by GSM · USA (original Chinese edition)
Photo: 图中是医务人员使用血压计为受检者测量血压。U.S. Marine Corps photo by Cpl. Jesse K. Alwin, via Wikimedia Commons

